§ 21a-70e — Pharmaceutical or medical device manufacturing company. Adoption of code on interaction with health care professionals and comprehensive compliance program. Civil penalty.

Connecticut § 21a-70e

• Jurisdiction: Connecticut
• Title 21a: Consumer Protection
• Ch. 417: General Provisions. Pure Food and Drugs

Text

(a) On or before January 1, 2011, each pharmaceutical or medical device manufacturing company shall adopt and implement a code that is consistent with, and minimally contains all of the requirements prescribed in, the Pharmaceutical Research and Manufacturers of America's “Code on Interaction with Healthcare Professionals” or AdvaMed's “Code of Ethics on Interactions with Health Care Professionals” as such codes were in effect on January 1, 2010. (b) Each pharmaceutical or medical device manufacturing company shall adopt a comprehensive compliance program in accordance with the guidelines provided in the “Compliance Program Guidance for Pharmaceutical Manufacturers” dated April, 2003 and issued by the United States Department of Health and Human Services Office of Inspector General. (c) Upon complaint, the department may investigate an alleged (1) violation of subsection (a) of this section, or (2) failure to conduct any training program or regular audit for compliance with the code adopted pursuant to subsection (a) of this section by a pharmaceutical or medical device manufacturing company. The Commissioner of Consumer Protection may impose a civil penalty of not more than five thousand dollars for any violation of the provisions of this section.

Legislative History

(P.A. 10-117, S. 94.)